References
- Azzi A, Boscobionik D, Marilley D, Ozer NK, Stauble B & Tashmoto A (1995): Vitamin E a sensor and information transducer of the cell oxidation status. Am. J. Clin. Nutr. 62 (Suppl.), 1337–1346.
- Boscobionik D, Szewczyk A & Azzi A (1991): Alpha- tocopherol (vitamin E) regulates vascular smooth muscle cell proliferation and protein kinase activity. Arch. Biochem. Biophys. 286, 264–269.
- Castelli WP (1996): Lipids, risk factors and ischemic heart disease. Atherosclerosis 124, S1–S9.
- Devaraj S, Li D & Jialal I (1996): The effects of alpha-tocopherol supplementation on monocyte function: decreased lipid oxidation, interleukin 1 (beta) secretion, and monocyte adhesion to endothelium. J. Clin. Invest. 98, 756–763.
- Esterbauer H, Dieber-Rotheneder M, Waeg G, Puhl H & Tatzber F (1990): Endogenous antioxidants and lipopro- tein oxidation. Biochem. Soc. Trans. 18, 1059–1061.
- Godfried SL, Combs GFJ, Saroka JM & Dillingham LA (1989): Potentiation of atherosclerotic lesions in rabbits by a high dietary level of vitamin E. Br. J. Nutr. 61, 607–617.
- Hara A & Randin NS (1978): Lipid extraction of tissues with low toxicity solvent. Anal. Biochem. 90, 420–426.
- Hennekens CH, Buring JE & Manson JE (1996): Lack of effect of long term supplementation with beta-carotene on the incidence of malignant neoplasms and cardiovas-cular disease. N. Engl. J. Med. 334, 1145–1149.
- Holman RL, Mc Gill HC Jr, Strong JP & Geer JC (1958):_;
- Technics for studying atherosclerosis. Lab. Invest. 1, 42–47.
- Ledwozyw A, Michalak J, Stepien A & Kadziolka A (1986): The relationship between plasma triacylglycerols, choles- terol, total lipids and lipids peroxidation products during human atherosclerosis. Clin. Chim. Acta 155, 275–284. Nafeeza MI, Kamsiah J, Vasudevan SK & Suhaimi H (1995): Effects of nicardipine on lipid peroxidation in rabbits given 2% cholesterol diet. J. Pharm. Toxicol. 77,10–15.
- Ollson AG & Yuan XM (1996): Antioxidants in the prevention of atherosclerosis. Curr. Opin. Lipidol. 7, 374–380.
- Pearce BC, Parker RA, Deason ME, Qureshi AA & Wright JJK (1992): Hypocholesterolemic activity of synthetic and natural tocotrienols. J. Med. Chem. 268, 1230–1238.
- Prabhat J, Flather M, Lonn E, Farkouh M & Yusaf S (1995): The antioxidant vitamins and cardiovascular disease: a critical review and clinical trial data. Ann. Int. Med. 123(11), 860–872.
- Prasad K & Kalra J (1989): Experimental atherosclerosis and oxygen free radicals. Angiology 40, 835–843.
- Prasad K & Kalra J (1993): Oxygen free radicals and hypercholesterolemic atherosclerosis: effect of vitamin E. Am. Heart J. 125, 958–973.
- Qureshi AA, Burger WS, Peterson DM & Elson CE (1986): The structure on an inhibitor of cholesterol biosynthesis isolated from barley. J. Biol. Chem. 261, 10544–10550.
- Qureshi AA, Qureshi N, Wright JJK, Shen Z, Kramer G, Gapor A, Chong YH, DeWitt G, Ong ASH, Peterson DM & Bradlow BA (1991): Lowering of serum cholesterol in hypercholesterolemic humans by tocotrienols (Palmvi- tee). Am. J. Clin. Nutr. 53, 1021S–1026S.
- Sassen LMA, Lamers JMJ, Hartog JM, Dekkers DHW & Verdouw PD (1990): Failure of diltiazem to suppress cholesterol-induced atherogenesis of endothelium-denu-dated arteries in pigs. Atherosclerosis 63, 125–135.
- Schwenke DC & Behr SR (1998): Vitamin E combined with selenium inhibits atherosclerosis in hypercholesterolemic rabbits independently of effects on plasma cholesterol concentration: Circ. Res. 83(4), 366–377.
- Serbinova EA, Kagan VE, Han D & Packer L (1991): d-Alpha tocotrienol is more powerful membrane anti- oxidant than d-alpha tocopherol. In: Oxidative Damage and Repair. Oxford: Pergamon Press.
- Stampfer M, Hennekens C, Manson JE, Colditz GA & Rosner B (1993): Vitamin E consumption and the risk of coronary heart disease in women. N. Engl. J. Med. 328(20), 1444–1449.
- Stephens NG, Parsons A, Schofield PM, Kelly F, Cheese- man K & Mitcchinson MJ (1996): Randomised con- trolled trial of vitamin E in patients with coronary heart disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet 347, 781–786.
- Singh RB, Singh NK, Rastogi SS, Wander GS, Aslam M, Onouchi Z, Kummerow FA & Nangia S (1997): Anti- oxidant effects of lovastation and vitamin E on experi- mental atherosclerosis in rabbit. Cardiovasc. Drugs Therapy 11(4), 575–580.
- Suarna C, Hood RL, Dean RT & Stocker R (1993): Comparative antioxidant activity of tocotrienols and other natural lipid soluble antioxidants in a homogenous system, and in rat and human lipoproteins. Biochem. Biophys. Acta. 1166, 163–170.
- Sugano M, Nakashima Y, Tasaki H, Takasugi M, Kuroiwa A & Koide O (1988): Effects of diltiazem on suppression and regression of experimental atherosclerosis. Br. J. Exp. Pathol. 69, 515–523.
- Suzukawa M, Ishikawa T, Yoshids H & Nakamura H (1995): Effect of in vivo supplementation with low dose vitamin E on susceptibility of low-density lipoprotein and high-density lipoprotein to oxidative modification. J. Am. Coll. Nutr. 14, 46–52.
- Viswanathan NM, Bhakthan NMG & Rockebie RA (1979): Effect of dietary supplementation of vitamin E on serum lipids and lipoproteins in rabbits fed a cholesterolemic diet. Int. J. Vit. Nutr. Res. 49, 370–375.
- Westrope KL, Miller RA & Wilson RB (1982): Vitamin E in rabbit model of endogenous hypercholesterolemia and atherosclerosis. Nutr. Rep. Int. 25, 83–89.
- Willingham AK, Bolanos C, Bohannan E & Cenedella RJ (1993): The effects of high level vitamin E on the progression of atherosclerosis in the Watanabe heritable hyperlipidemic rabbit. J. Nutr. Biochem. 4, 651–654.
- Wilson RB, Middleton CC & Sun GY (1978): Vitamin E, antioxidants and lipid peroxidation in experimental atherosclerosis of rabbits. J. Nutr. 108, 1858–1867.
- Wojcicki J, Samochowiec L, Jaworska M & Hinek A (1985): A search for a model of experimental athero- sclerosis: comparative studies in rabbits, guinea pigs and rats. J. Pharm. Pharmacol. 37, 11–21.